Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (61-70 of 917) with videos related to

Pageof 92
Sort By:
European Urology Focus|June 26, 2026
Postoperative Pelvic Lymph Node Radiation Therapy in Lymph Node-Positive Prostate Cancer and Mortality RiskMutlay Sayan, Yetkin Tuac, Markus Graefen, et al.
European Urology|October 17, 2020
Re: Paolo Afonso de Carvalho, Joāo A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes. Eur Urol 2020;77:628-35: Incredible Results for Robot-assisted Nerve-sparing Radical Prostatectomy in Prostate Cancer PatientsFrancesco Montorsi, Giorgio Gandaglia, Christoph Würnschimmel, et al.
The Prostate|June 16, 2015
Impact of prostate volume on oncologic, perioperative, and functional outcomes after radical prostatectomyPhilipp Mandel, Philipp Weinhold, Uwe Michl, et al.
Molecular Diagnosis & Therapy|January 29, 2013
Assays for prostate cancer : changing the screening paradigm?Jens Hansen, Michael Rink, Markus Graefen, et al.
European Urology|August 6, 2002
Patient-reported sexual function after nerve-sparing radical retropubic prostatectomyJoachim Noldus, Uwe Michl, Markus Graefen, et al.
European Urology|November 15, 2011
Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendationsDionysios Mitropoulos, Walter Artibani, Markus Graefen, et al.
European Urology Focus|August 7, 2024
External Validation of Stockholm3 in a Retrospective German Clinical CohortDerya Tilki, Niclas Rejek, Florian Nohe, et al.
The Canadian Journal of Urology|August 26, 2010
Analysis of testosterone suppression in men receiving histrelin, a novel GnRH agonist for the treatment of prostate cancerBob Djavan, Peter Schlegel, Georg Salomon, et al.
European Urology Oncology|July 3, 2024
Mortality Risk for Patients with Biopsy Gleason Grade Group 1 Prostate CancerDerya Tilki, Ming-Hui Chen, Hartwig Huland, et al.
Prostate Cancer and Prostatic Diseases|January 6, 2025
Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancerReha-Baris Incesu, Felix Preisser, Florian Nohe, et al.
Pageof 92

Showing results (61-70 of 917) with videos related to

Sort By:
Pageof 92
European Urology Focus|June 26, 2026
Postoperative Pelvic Lymph Node Radiation Therapy in Lymph Node-Positive Prostate Cancer and Mortality RiskMutlay Sayan, Yetkin Tuac, Markus Graefen, et al.
European Urology|October 17, 2020
Re: Paolo Afonso de Carvalho, Joāo A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes. Eur Urol 2020;77:628-35: Incredible Results for Robot-assisted Nerve-sparing Radical Prostatectomy in Prostate Cancer PatientsFrancesco Montorsi, Giorgio Gandaglia, Christoph Würnschimmel, et al.
The Prostate|June 16, 2015
Impact of prostate volume on oncologic, perioperative, and functional outcomes after radical prostatectomyPhilipp Mandel, Philipp Weinhold, Uwe Michl, et al.
Molecular Diagnosis & Therapy|January 29, 2013
Assays for prostate cancer : changing the screening paradigm?Jens Hansen, Michael Rink, Markus Graefen, et al.
European Urology|August 6, 2002
Patient-reported sexual function after nerve-sparing radical retropubic prostatectomyJoachim Noldus, Uwe Michl, Markus Graefen, et al.
European Urology|November 15, 2011
Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendationsDionysios Mitropoulos, Walter Artibani, Markus Graefen, et al.
European Urology Focus|August 7, 2024
External Validation of Stockholm3 in a Retrospective German Clinical CohortDerya Tilki, Niclas Rejek, Florian Nohe, et al.
The Canadian Journal of Urology|August 26, 2010
Analysis of testosterone suppression in men receiving histrelin, a novel GnRH agonist for the treatment of prostate cancerBob Djavan, Peter Schlegel, Georg Salomon, et al.
European Urology Oncology|July 3, 2024
Mortality Risk for Patients with Biopsy Gleason Grade Group 1 Prostate CancerDerya Tilki, Ming-Hui Chen, Hartwig Huland, et al.
Prostate Cancer and Prostatic Diseases|January 6, 2025
Negative PSMA PET can be used to avoid unnecessary pelvic lymph node dissection in intermediate risk prostate cancerReha-Baris Incesu, Felix Preisser, Florian Nohe, et al.
Pageof 92